Recent advances in the physiology and pharmacology of the bladder

Current Opinion in Urology

Volumn 6, Issue 4, 1996, Pages 196-199

  Andersson, Karl Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CROMAKALIM; DARIFENACIN; GUANOSINE PHOSPHATE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N (4 BENZOYLPHENYL) 3,3,3 TRIFLUORO 2 HYDROXY 2 METHYLPROPIONAMIDE; NITRIC OXIDE; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; TOLTERODINE; UNCLASSIFIED DRUG; VAMICAMIDE;

BLADDER DISEASE; BLADDER FUNCTION; CLINICAL TRIAL; DETRUSOR DYSSYNERGIA; DETRUSOR MUSCLE; HUMAN; NONHUMAN; PHARMACOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; URINARY TRACT FUNCTION; URINE INCONTINENCE;

EID: 0029742983     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199607000-00007     Document Type: Short Survey

References (42)

1. Burnett AL: Nitric oxide control of lower genitourinary tract functions: • a review. Urology 1995, 45:1071-1083. An overview of possible functions of NO in, for example, penis, bladder and male genital tract.
2. Alm P, Zygmunt PKE, Iselin C, Larsson B, Uvelius B, Werner S, Andersson K-E: Nitric oxide synthase-immunoreactive, adrenergic, cholinergic, and peptidergic nerves of the female rat urinary tract: a comparative study. J Auton Nerv Syst 1995, 56:105-114.
3. Persson K, Aim P, Johansson K, Larsson B, Andersson K-E: Co-existence of nitrergic, peptidergic and acetylcholine esterase-posrtive nerves in the pig lower urinary tract J Auton Nerv Syst 1995, 52:225-236.
4. Andersson K-E, Persson K: Nitric oxide synthese and the lower • urinary tract: possible implications for physiology and pathophysiology. Scand J Urol Nephrol 1995, 29(suppl 175):43-53. An overview of the distribution of neurogenic NOS and functional and biochemical effects of NO in the lower urinary tract.
5. Williams P, Datta S, German K, Stephenson TP, Bedwani JR: Comparison of relaxation responses of detrusor strips from neuropathic and control patients. Br J Urol 1995, 76:726-729.
6. Ehren I, Iversen H, Jansson O, Adolfsson J, Wiklund NP: Localization of nitric oxide synthese activity in the human lower urinary tract and its correlation with neuroeffector responses. Urology 1994, 44:683-687.
7. Takeda M, Lepor H: Nitric oxide synthase in dog urethra: a histochemicäl and pharmacological analysis. Br J Pharmacol 1995, 116:2517-2523.
8. Bennett BC, Kruse MN, Roppolo JR, Flood HD, Fraser M, de Groat WC: • Neural control of urethral outlet activity in vivo: role of nitric oxide. J Urol 1995, 153:2004-2009. Demonstration of a reflex relaxation of the outflow region of female rats, mediated by NO, at the start of micturition.
9. Flood HD, Fraser MO, Yoshiyama M, Somogyi GT, de Groat WC: Nitric oxide (NO) mediated urethral relaxation is present in vivo in the female but not in the male rat [Abstract]. J Urol 1995, 153:135.
10. Kakizaki H, de Groat WC: Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation. J Urol 1995, 155:355-360.
11. Wein AJ: Pharmacology of incontinence. Urol Clin North Am 1995, 22:557-577.
12. Eglen RM, Watson N: Selective muscarinic receptor agonists and • antagonists. Pharmacol Toxicol 1996, 78:59-68. An up-to-date review of muscarinic receptor subtypes and of drugs for their selective stimulation and blockade.
13. Kondo S, Morita T, Tashima Y: Muscarinic cholinergic receptor •• subtypes in human detrusor muscle studied by labeled and nonlabeled pirenzepine, AFDX-116, and 4DAMP. Urol Int 1995, 54:150-153. Demonstration of M1, M2, and M3 receptors in the human bladder by ligand-binding experiments. Interestingly, a predominance of M3 receptors is shown.
14. Wammack R, Weihe E, Dienes H-P, Hohenfellner R: The neurogenic •• bladder in vitro [in German]. Aktuel Urol 1995, 28:16-18. Important, new observations on neurotransmission in the neurogenic bladder.
15. Wang P, Luthin GR, Ruggieri MR: Muscarinic acetylcholine receptor •• subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J Pharmacol Exp Ther 1995, 273:959-956. Interesting observations on the muscarinic receptor subtypes in bladder membranes from several species. Using subtype-specific immunoprecipitation, only M2 and M3 subtypes could be demonstrated in human detrusor membranes.
16. Longhurst PA, Leggett RE, Briscoe JAK: Characterization of the functional muscarinic receptors in the rat urinary bladder. Br J Pharmacol 1995, 116:2279-2285.
17. Newgreen DT, Anderson CWP, Carter AJ, Naylor AM: Darifenacin - a novel bladder-selective agent for the treatment of urge incontinence. Neurourol Urodyn 1995, 14:95-96.
18. 3 antagonist [Abstract]. Pharmacol Res 1990, 31(suppl):54.
19. Oyasu H, Yamamoto T, Sato N, Ozaki R, Mukai T, Ozaki T, Nishii T, Sato H, Fujisawa T, Tozuka Z et al.: Urinary bladder selective action of the new antimuscarinic compound vamicamide. Arzneimittel Forsch 1994, 44:1242-1249.
20. Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M: Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol 1995, 154:2174-2178.
21. Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shinomura K: General pharmacology of the new antimuscarinic compound vamicamide. Arzeimittel-Forschung 1995, 45:1274-1284.
22. Nilvebrant L, Glas G, Jönsson Å, Sparf B: The in-vitro pharmacological profile of tolterodine - a new agent for the treatment of urinary urge incontinence. Neurourol Urodyn 1994, 13:433-435.
23. Gillberg P-G, Modiri A-R, Sparf B: Tolterodine - a new agent with tissue effect selectivity for urinary bladder. Neurourol Urodyn 1994, 13:435-436.
24. Stahl MMS, Ekström B, Sparf B, Mattiasson A, Andersson K-E: Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity. Neurourol Urodyn 1995, 14:647-655.
25. Rentzhog L, Abrams P, Cardozo L Fall M, Nelson E, Stanton S: Tolterodine - a new bladder selective drug for the treatment of detrusor instability [Abstract]. Proc. of the 25th Annual Meeting of the International Continence Society: Sydney, Oct 17-20, 1995:42-43.
26. Somogyi GT, Tanowitz M, de Groat WC: M1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder. J Physiol 1994, 480:81-89.
27. 3H]-acetylcholine release in the rabbit urinary bladder. Eur J Pharmacol 1995, 281:1-8.
28. Flood HD, Somogyi GT, Bellinger MF, de Groat WC: Muscarinic facilitation of acetylcholine release in the human bladder: a mechanism for enhancement of micturition contractions [Abstract]. Proc. of the 24th Annual Meeting of the International Continence Society; Prague, Aug 31-Sept 2, 1994:62-63.
29. 3H-acetylcholine secretion in the guinea pig urinary bladder in vitro. J Pharmacol Exp Ther 1995, 274:458-468.
30. Andersson K-E: Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 1993, 45:253-308.
31. 3H]α,β-methylene adenosine 5′-triphosphate binding sites in human urinary bladder. Br J Urol 1995, 76:297-302.
32. Palea S, Pietra C, Trist DG, Artibani W, Calpista A, Corsi M: Evidence for the presence of both pre- and postjunctional P2-purinoceptor subtypes in human isolated urinary bladder. Br J Pharmacol 1995, 114:35-40.
33. Smith DJ, Chapple CR: In-vitro response of human bladder smooth muscle in unstable obstructed male bladders: a study of pathophysiological causes. Neurourol Urodyn 1994, 13:414-415.
34. Trivedi S, Potter-Lee L, Li JH, Yasay GD, Russell K, Ohnmach CJ, Empfield JR, Trainor DA, Kau ST: Calcium dependent K-channels in guinea pig and human urinary bladder. Biochem Biophys Res Commun 1995, 213:404-409.
35. Edwards G, Henshaw M, Miller M, Weston AH: Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro. Br J Pharmacol 1991, 102:679-686.
36. Hedlund H, Mattiasson A, Andersson K-E: Effects of pinacidil on detrusor instability in men with outlet obstruction. J Urol 1991, 146:1345-1347.
37. Komersova K, Rogerson JW, Conway EL, Lim TC, Brown DJ, Krum H, Jackman GP, Murdoch R, Louis WJ: The effect of Levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions. Br J Pharmacol 1995, 39:207-209.
38. +-channel opener with possible in-vivo selectivity for the bladder.
39. Masuda N, Uchida W, Shirai Y, Shibasaki K, Goto K, Takenaka T: Effect of the potassium channel opener YM934 on the contractile response to electrical field stimulation in pig detrusor smooth muscle. J Urol 1995, 154:1914-1920.
40. ATP channel opening activity in bladder detrusor. Pharmacology 1995, 52:33-42.
41. 3H-P1075 binding in bladder smooth muscle. Pharmacology 1995, 50:388-397.
42. Green ME, Edwards G, Brady G, Clarke N, O'Flynn K, Weston AH: Potassium channel modulation by ZD6169, Levcromakalim and NS 1619 in rat and human bladder detrusor muscle [Abstract]. Br J Pharmacol 1995, 116:176P.